An overview of intravesical therapy for superficial bladder tumors.

Suppr

超能文献

作者信息

Herr H W, Laudone V P, Whitmore W F

机构信息

Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.

出版信息

J Urol. 1987 Dec;138(6):1363-8. doi: 10.1016/s0022-5347(17)43644-5.

DOI:10.1016/s0022-5347(17)43644-5

PMID:3316712

Abstract

摘要

相似文献

An overview of intravesical therapy for superficial bladder tumors.

J Urol. 1987 Dec;138(6):1363-8. doi: 10.1016/s0022-5347(17)43644-5.

Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.

Anticancer Res. 2001 Jan-Feb;21(1B):765-9.

Intravesical therapy. A critical review.

Urol Clin North Am. 1987 May;14(2):399-404.

Only an overall 15% net benefit emerges in favour of adjuvant intravesical chemotherapy when compared to transurethral resection alone for the prevention of recurrences of superficial bladder tumors.

Eur Urol. 2006 Aug;50(2):233-4.

New approaches to intravesical chemo-immunotherapy in superficial bladder cancer.

Prog Clin Biol Res. 1992;378:95-101.

[Intravesical therapy: Influence on superficial bladder cancer recurrence].

Arch Esp Urol. 2007 Jan-Feb;60(1):36-43.

BCG versus cytotoxic chemotherapy in the treatment of superficial bladder tumors.

Prog Clin Biol Res. 1992;378:55-7.

Is immediate postoperative intravesical chemotherapy beneficial in non-muscle- invasive bladder cancer?

BJU Int. 2010 Feb;105 Suppl 2:14-7. doi: 10.1111/j.1464-410X.2009.09152.x.

Superficial bladder cancer T1G3: the choice of treatment.

BJU Int. 2002 Apr;89(6):623-7. doi: 10.1046/j.1464-410x.2002.02696.x.

Point. Routine use of postoperative intravesical chemotherapy after TURBT-should it be done?

Urology. 2010 Oct;76(4):794-6. doi: 10.1016/j.urology.2010.04.069.

引用本文的文献

Intravesical gemcitabine versus mitomycin for non-muscle invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trial.

BMC Urol. 2020 Jul 13;20(1):97. doi: 10.1186/s12894-020-00610-9.

Can we treat bladder cancer with intravesical Bacillus Calmette-Guerin in patients with prior tuberculosis infection? A population-based cohort study.

BMC Urol. 2020 Jul 8;20(1):91. doi: 10.1186/s12894-020-00642-1.

Periostin suppresses invasiveness via PDK1/Akt/mTOR signaling pathway in a mouse orthotopic model of bladder cancer.

Oncol Lett. 2017 Jun;13(6):4276-4284. doi: 10.3892/ol.2017.6004. Epub 2017 Apr 7.

Intravesical administration of pirarubicin against superficial bladder cancer: Relationship between tumor tissue concentration and exposure time in the bladder or therapeutic effect.

Exp Ther Med. 2011 Sep;2(5):901-905. doi: 10.3892/etm.2011.315. Epub 2011 Jun 30.

Biopsies of the normal-appearing urothelium in primary bladder cancer.

Urol Ann. 2010 May;2(2):71-5. doi: 10.4103/0974-7796.65115.

Epirubicin: a review of its intravesical use in superficial bladder cancer.

Drugs Aging. 1999 Oct;15(4):307-33. doi: 10.2165/00002512-199915040-00006.

Intravesical drug delivery. Pharmacokinetic and clinical considerations.

Clin Pharmacokinet. 1999 Jul;37(1):59-73. doi: 10.2165/00003088-199937010-00004.

Bladder cancer.

BMJ. 1998 Nov 14;317(7169):1366-9. doi: 10.1136/bmj.317.7169.1366.

Prospective randomized comparison of intravesical BCG therapy with standard dose versus low doses in superficial bladder cancer.

Int Urol Nephrol. 1998;30(1):41-4. doi: 10.1007/BF02550276.

Cytokine-mediated antitumor effect of OK-432 on urinary bladder tumor cells in vitro.

Urol Res. 1997;25(4):239-45. doi: 10.1007/BF00942092.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验